SCHEMBL2366964

SCHEMBL2366964

CONC(C)Cc1ccc(Cl)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2C19 P33261 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
CYP2D6 P10635 2/20 0.48
ALOX15 P16050 1/20 0.48
HTT P42858 2/20 0.46
MAPK1 P28482 2/20 0.45
GAA P10253 1/20 0.43
IDO1 P14902 3/20 0.43
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP2C9 P11712 2/20 0.42
POLB P06746 1/20 0.42
SLC6A4 P31645 1/20 0.41
HDAC8 Q9BY41 2/20 0.41
ALDH1A1 P00352 1/20 0.40
PYCR1 P32322 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2367025 0.85 CYP3A4 (0.47) CYP1A2CYP3A4CYP2C19MEN1KMT2A
SCHEMBL2367386 0.84 CYP3A4 (0.46) CYP1A2CYP3A4CYP2C19MEN1KMT2A
SCHEMBL9978632 0.80 HTT (0.43) CYP1A2CYP3A4CYP2C19MEN1KMT2A
SCHEMBL2367303 0.79 CYP1A2 (0.68) CYP1A2CYP3A4CYP2C19MEN1KMT2A
SCHEMBL23794996 0.77 SLC6A4 (0.41) CYP1A2CYP2C19MEN1KMT2ACYP2D6
SCHEMBL16335384 0.77 SLC6A4 (0.41) CYP1A2CYP2C19MEN1KMT2ACYP2D6
SCHEMBL9729609 0.77 IDO1 (0.47) CYP1A2CYP3A4CYP2C19MEN1KMT2A
SCHEMBL2366778 0.77 SLC6A4 (0.41) CYP1A2CYP2C19MEN1KMT2ACYP2D6
SCHEMBL2659771 0.76 IDO1 (0.54) CYP1A2CYP3A4CYP2C19MEN1KMT2A
SCHEMBL2367062 0.75 SLC6A4 (0.64) CYP1A2MEN1KMT2ACYP2D6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013801-B1 PROCESS FOR THE STEREOSELECTIVE PREPARATION OF A PYRAZOLE-CARBOXAMIDE SYNGENTA PARTICIPATIONS AG (CH) 2018-08-22 EP disclosed
US-9637457-B2 Process for the stereoselective preparation of a pyrazole-carboxamide SYNGENTA PARTICIPATIONS AG (CH) 2017-05-02 US disclosed
EP-3013801-A1 PROCESS FOR THE STEREOSELECTIVE PREPARATION OF A PYRAZOLE-CARBOXAMIDE Syngenta Participations AG (CH) 2016-05-04 EP disclosed
US-20160108001-A1 PROCESS FOR THE STEREOSELECTIVE PREPARATION OF A PYRAZOLE-CARBOXAMIDE SYNGENTA PARTICIPATIONS AG (CH) 2016-04-21 US disclosed
WO-2014206855-A1 PROCESS FOR THE STEREOSELECTIVE PREPARATION OF A PYRAZOLE-CARBOXAMIDE SYNGENTA PARTICIPATIONS AG (CH) 2014-12-31 WO disclosed
EP-2364293-B1 NOVEL PYRAZOLE-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2013-01-23 EP disclosed
EP-2364293-B1 NOVEL PYRAZOLE-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2013-01-23 EP disclosed
US-8258169-B2 Pyrazole-4-N-alkoxycarboxamides as microbiocides SYNGENTA CROP PROTECTION, LLC (US) 2012-09-04 US disclosed
US-8258169-B2 Pyrazole-4-N-alkoxycarboxamides as microbiocides SYNGENTA CROP PROTECTION, LLC (US) 2012-09-04 US disclosed
US-8258169-B2 Pyrazole-4-N-alkoxycarboxamides as microbiocides SYNGENTA CROP PROTECTION, LLC (US) 2012-09-04 US disclosed
US-20110230537-A1 NOVEL PYRAZOLE-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES SYNGENTA CROP PROTECTION LLC (US) 2011-09-22 US disclosed
US-20110230537-A1 NOVEL PYRAZOLE-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES SYNGENTA CROP PROTECTION LLC (US) 2011-09-22 US disclosed
US-20110230537-A1 NOVEL PYRAZOLE-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES SYNGENTA CROP PROTECTION LLC (US) 2011-09-22 US disclosed
EP-2364293-A2 NOVEL MICROBIOCIDES Syngenta Participations AG (CH) 2011-09-14 EP disclosed
WO-2010063700-A2 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-06-10 WO disclosed
WO-2010063700-A2 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230537-A1 NOVEL PYRAZOLE-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES CASP1, CASP14, CD14 CYP1A2 202/4885CYP3A4 92/4885CYP2C19 113/4885
US-20160108001-A1 PROCESS FOR THE STEREOSELECTIVE PREPARATION OF A PYRAZOLE-CARBOXAMIDE CYP3A4, CYP2C9, CYP2C19 CYP1A2 25/4885CYP3A4 1/4885CYP2C19 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.